The potential benefits of green tea in patients with uveitis.
Rahimi
Mansour
M
Moinfar
Nader
N
Ashrafi
Afsaneh
A
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000975:Antioxidants / Q000378:metabolism; D002392:Catechin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005492:Folic Acid / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007249:Inflammation / Q000628:therapy; D008727:Methotrexate / Q000494:pharmacology; D008954:Models, Biological; D008962:Models, Theoretical; D013662:Tea / Q000378:metabolism*; D014605:Uveitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D007166:Immunosuppressive Agents; D013662:Tea; D002392:Catechin; D005492:Folic Acid; C045651:epigallocatechin gallate; D008727:Methotrexate